Trial Profile
Prospective, multicenter, parallel, single-blinded, randomized, non-inferiority clinical study to evaluate the reduction of cold or flu symptoms with Fluviral® compared to Resfenol®, in adult participants
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 10 Feb 2017
Price :
$35
*
At a glance
- Drugs GSK 1536489A (Primary) ; Chlorphenamine; Paracetamol; Phenylephrine
- Indications Influenza virus infections
- Focus Therapeutic Use
- 10 Feb 2017 New trial record